drugset

drugset / Trial / NCT04054492

To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV

NCT04054492 ↗

Phase 4 Completed 604 enrolled China National Biotec Group Company Limited Hubei Provincial Center for Disease Control and Prevention · collab Inner Mongolia Autonomous Region Center for Diseases Prevention and Control · collab Peking University · collab Shaanxi Provincial Center for Disease Control and Prevention · collab

RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to evaluate the immunogenicity and safety of sequential immunization schedules of Sabin IPV and bOPV.

Timeline

Start: 2018-03-01
Primary completion: 2019-01-25
Completion: 2019-06-12

Publications

Yan S, Chen H, Zhang Z, Chang S, Xiao Y, Luo L, Zhang Z, Sun L, Chen X, Yang Y, Shi X, Guo Y, Sun Y, Li H, Li N, Han S, Ma M, Yang X. Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China. Vaccine. 2020 Sep 11;38(40):6274-6279. doi: 10.1016/j.vaccine.2020.07.042. Epub 2020 Jul 31.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sabin-IPV	Vaccine	—	—
Subject	bivalent oral poliovirus vaccine	Vaccine	—	—

Indications

No indication recorded.